Anika Therapeutics Inc. Share Price

Anika Therapeutics Inc. Share Price

NASDAQ: ANIK | Small Cap
$21.80
+$0.32 (1.47%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Anika Therapeutics Inc. Stock Performance

Open
$21.73
Prev. Close
$21.48
Circuit Range
N/A
Day Range
$21.41 - $21.73
Year Range
$9.03 - $22.35
Volume
2,973
Average Traded
$21.51

Anika Therapeutics Inc. Share Price Today

As of 30 October 2026, Anika Therapeutics Inc.'s share price is $21.80. The stock opened at $21.73, compared to its previous close of $21.48. During today's trading session, Anika Therapeutics Inc.'s share price traded between $21.41 and $21.73, with an average price of $21.57. Over the past 52 weeks, the stock has recorded a high of $22.35 and a low of $9.03. In terms of performance, Anika Therapeutics Inc.'s share price has risen by 75.52% over the last six months and is up 122.45% on a year-on-year basis.

Anika Therapeutics Inc. Share Price Chart

Line chart of the Anika Therapeutics Inc. price trend over the selected period. The price rose overall, ranging from 21.36 to 21.80, ending at 21.80.
$21.41$21.73
L
Show Current Price
H

Anika Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$312.59M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.28
Revenue (TTM)
$112.82B
Return On Equity (TTM)
-2.76%
Profit Margin
-9.64%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
242.06%

Anika Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$27.82$30.62$29.61$32.61
Net Profit-$2.33$0.29-$5.06$3.31
Net Profit Margin-8.38%0.95%-17.09%10.15%
Income ChangeN/A112.45%-1844.83%165.42%

Anika Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$113.83$120.79$119.91$112.82
Net Profit-$14.86-$82.67-$56.39-$10.88
Net Profit Margin-13.05%-68.44%-47.03%-9.64%
Income ChangeN/A-456.33%31.79%80.71%

About Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Anika Therapeutics Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$19.25
$21.56
+9.44%
Sep 2026
$21.20
$19.70
-5.97%
Aug 2026
$19.88
$20.95
+8.94%
Jul 2026
$15.09
$19.23
+31.94%
Jun 2026
$14.13
$14.57
-0.58%
May 2026
$13.84
$14.66
+18.04%
Apr 2026
$14.64
$12.42
-14.17%
Mar 2026
$14.61
$14.47
+1.08%
Feb 2026
$9.43
$14.31
+54.92%
Jan 2026
$9.61
$9.24
-3.85%
Dec 2025
$9.79
$9.61
-2.73%
Nov 2025
$9.88
$9.88
+0.82%

ANIK Share Price FAQs